News
Atai Life Sciences’ psychedelic drug has successfully reduced the symptoms of depression in a phase 2 study, triggering the ...
26m
InvestorsHub on MSNATAI Life Sciences Shares Soar Following Strong Phase 2b Results for Depression TreatmentShares of ATAI Life Sciences (NASDAQ:ATAI) skyrocketed 29% on Tuesday after the biotech company and its partner, Beckley ...
The National Hurricane Center on Tuesday increased the odds a low pressure system expected to form later this week near ...
Walking 10,000 steps daily is seen as a fitness goal by many. But experts say it began as marketing, not medical advice, and ...
Investing.com -- ATAI Life Sciences (NASDAQ: ATAI) stock surged 29% after the company and its partner Beckley Psytech announced positive topline results from a Phase 2b study of BPL-003 in patients ...
24m
Racine County Eye on MSNMen Need to Know that It’s Ok to FeelMen need to know that it’s ok to feel, that it’s ok to ask for help, and not a sign of weakness to seek a therapist or mental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results